Literature DB >> 20332261

Genetic susceptibility variants for chronic lymphocytic leukemia.

Susan L Slager1, Lynn R Goldin, Sara S Strom, Mark C Lanasa, Logan G Spector, Laura Rassenti, Jose F Leis, Nicola J Camp, Neil E Kay, Celine M Vachon, Martha Glenn, J Brice Weinberg, Kari G Rabe, Julie M Cunningham, Sara J Achenbach, Curtis A Hanson, Gerald E Marti, Timothy G Call, Neil E Caporaso, James R Cerhan.   

Abstract

BACKGROUND: There is strong and consistent evidence that a genetic component contributes to the etiology of chronic lymphocytic leukemia (CLL). A recent genome-wide association study of CLL identified seven genetic variants that increased the risk of CLL within a European population.
METHODS: We evaluated the association of these variants, or variants in linkage disequilibrium with these variants, with CLL risk in an independent sample of 438 CLL cases and 328 controls.
RESULTS: Of these seven single nucleotide polymorphisms (SNP), six had P trend < 0.05 and had estimated odds ratios (OR) that were strikingly comparable to those of the previous study. Associations were seen for rs9378805 [OR, 1.47; 95% confidence intervals (CI), 1.19-1.80; P trend = 0.0003] near IRF4 and rs735665 near GRAMD1B (OR, 1.47; 95% CI, 1.14-1.89; P trend = 0.003). However, no associations (P > 0.05) were found for rs11083846, nor were any found for any SNP in linkage disequilibrium with rs11083846.
CONCLUSIONS: Our results confirm the previous findings and further support the role of a genetic basis in the etiology of CLL; however, more research is needed to elucidate the causal SNP(s) and the potential manner in which these SNPs or linked SNPs function in CLL pathogenesis.

Entities:  

Mesh:

Year:  2010        PMID: 20332261      PMCID: PMC2852480          DOI: 10.1158/1055-9965.EPI-09-1217

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  12 in total

Review 1.  Susceptibility genes and B-chronic lymphocytic leukaemia.

Authors:  Susan L Slager; Neil E Kay; Zachary S Fredericksen; Alice H Wang; Mark Liebow; Julie M Cunningham; Celine M Vachon; Timothy G Call; James R Cerhan
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

2.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

3.  Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.

Authors:  D Heintel; N Zojer; M Schreder; K Strasser-Weippl; B Kainz; M Vesely; H Gisslinger; J Drach; A Gaiger; U Jäger; H Ludwig
Journal:  Leukemia       Date:  2007-08-09       Impact factor: 11.528

4.  Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

5.  A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.

Authors:  Maria Chiara Di Bernardo; Dalemari Crowther-Swanepoel; Peter Broderick; Emily Webb; Gabrielle Sellick; Ruth Wild; Kate Sullivan; Jayaram Vijayakrishnan; Yufei Wang; Alan M Pittman; Nicola J Sunter; Andrew G Hall; Martin J S Dyer; Estella Matutes; Claire Dearden; Tryfonia Mainou-Fowler; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; Peter Hillmen; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; James M Allan; Daniel Catovsky; Richard S Houlston
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

6.  A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci.

Authors:  Gabrielle S Sellick; Emily L Webb; Ruth Allinson; Estella Matutes; Martin J S Dyer; Viggo Jonsson; Anton W Langerak; Francesca R Mauro; Stephen Fuller; James Wiley; Matthew Lyttelton; Vincenzo Callea; Martin Yuille; Daniel Catovsky; Richard S Houlston
Journal:  Am J Hum Genet       Date:  2005-08-02       Impact factor: 11.025

7.  A genome scan of 18 families with chronic lymphocytic leukaemia.

Authors:  Lynn R Goldin; Naoko Ishibe; Maria Sgambati; Gerald E Marti; Laura Fontaine; Maxwell P Lee; Jenny M Kelley; Titia Scherpbier; Kenneth H Buetow; Neil E Caporaso
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

8.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

9.  A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.

Authors:  Gabrielle S Sellick; Lynn R Goldin; Ruth W Wild; Susan L Slager; Laura Ressenti; Sara S Strom; Martin J S Dyer; Francesca R Mauro; Gerald E Marti; Stephen Fuller; Matthew Lyttelton; Thomas J Kipps; Michael J Keating; Timothy G Call; Daniel Catovsky; Neil Caporaso; Richard S Houlston
Journal:  Blood       Date:  2007-08-08       Impact factor: 22.113

10.  Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.

Authors:  A L Feldman; M Law; E D Remstein; W R Macon; L A Erickson; K L Grogg; P J Kurtin; A Dogan
Journal:  Leukemia       Date:  2008-11-06       Impact factor: 11.528

View more
  16 in total

Review 1.  Familial chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Susan L Slager; Neil E Caporaso
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

2.  Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.

Authors:  Susan L Slager; Kari G Rabe; Sara J Achenbach; Celine M Vachon; Lynn R Goldin; Sara S Strom; Mark C Lanasa; Logan G Spector; Laura Z Rassenti; Jose F Leis; Nicola J Camp; Martha Glenn; Neil E Kay; Julie M Cunningham; Curtis A Hanson; Gerald E Marti; J Brice Weinberg; Vicki A Morrison; Brian K Link; Timothy G Call; Neil E Caporaso; James R Cerhan
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

3.  Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.

Authors:  Jennifer L Kelly; Anne J Novak; Zachary S Fredericksen; Mark Liebow; Stephen M Ansell; Ahmet Dogan; Alice H Wang; Thomas E Witzig; Timothy G Call; Neil E Kay; Thomas M Habermann; Susan L Slager; James R Cerhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-20       Impact factor: 4.254

4.  The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.

Authors:  Charlie Zhong; Loren Gragert; Martin Maiers; Brian T Hill; Jean Garcia-Gomez; Ketevan Gendzekhadze; David Senitzer; Joo Song; Dennis Weisenburger; Leanne Goldstein; Sophia S Wang
Journal:  Leuk Lymphoma       Date:  2019-06-19

5.  Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans.

Authors:  Catherine C Coombs; Laura Z Rassenti; Lorenzo Falchi; Susan L Slager; Sara S Strom; Alessandra Ferrajoli; J Brice Weinberg; Thomas J Kipps; Mark C Lanasa
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

Review 6.  Personalized medicine in CLL: current status and future perspectives.

Authors:  Uri Rozovski; Inbal Hazan-Halevy; Michael J Keating; Zeev Estrov
Journal:  Cancer Lett       Date:  2013-07-20       Impact factor: 8.679

7.  Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias.

Authors:  Alex Yick-Lun So; Reeshelle Sookram; Aadel A Chaudhuri; Aarathi Minisandram; David Cheng; Catherine Xie; Ee Lyn Lim; Yvette Garcia Flores; Shuai Jiang; Jocelyn Tammy Kim; Christopher Keown; Parameswaran Ramakrishnan; David Baltimore
Journal:  Blood       Date:  2014-07-08       Impact factor: 22.113

Review 8.  Genomic approaches to chronic lymphocytic leukemia.

Authors:  Ma Reina Improgo; Jennifer R Brown
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

Review 9.  Genetic susceptibility to chronic lymphocytic leukemia.

Authors:  Susan L Slager; Neil E Caporaso; Silvia de Sanjose; Lynn R Goldin
Journal:  Semin Hematol       Date:  2013-10       Impact factor: 3.851

10.  Cost of illness and economic burden of chronic lymphocytic leukemia.

Authors:  Carl Rudolf Blankart; Taika Koch; Roland Linder; Frank Verheyen; Jonas Schreyögg; Tom Stargardt
Journal:  Orphanet J Rare Dis       Date:  2013-02-20       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.